-
Bactiguard completes a directed new share issue to AMF, raising approximately SEK 228 million
prnasia
September 23, 2021
The board of directors of Bactiguard Holding AB (publ) ("Bactiguard") has resolved on a directed new share issue of 1,500,000 B shares at a price of SEK 152 per share, corresponding to approximately SEK 228 million.
-
Bactiguard appoints new CEO
prnasia
September 08, 2021
The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO.
-
A large randomized clinical trial shows significant reduction in urinary tract infections
prnasia
March 12, 2021
A recently published, randomized, controlled multicenter study in India shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard ...
-
Bactiguard Launches Product That Protects Against Coronavirus
prnasia
March 12, 2020
Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds.
-
Bactiguard Completes Acquisition of Vigilenz
prnasia
March 03, 2020
Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.
-
New Major Order From China
prnasia
January 05, 2020
In June 2018, Bactiguard signed a combined distribution and license agreement with Well Lead, China's leading manufacturer of consumable medical devices.